[go: up one dir, main page]

FR2602145B3 - Nouvel agent de contraste pour les images de rmn, particulierement utile aux applications medicales de la rmn - Google Patents

Nouvel agent de contraste pour les images de rmn, particulierement utile aux applications medicales de la rmn

Info

Publication number
FR2602145B3
FR2602145B3 FR878710723A FR8710723A FR2602145B3 FR 2602145 B3 FR2602145 B3 FR 2602145B3 FR 878710723 A FR878710723 A FR 878710723A FR 8710723 A FR8710723 A FR 8710723A FR 2602145 B3 FR2602145 B3 FR 2602145B3
Authority
FR
France
Prior art keywords
nmr
contrast agent
especially useful
medical
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR878710723A
Other languages
English (en)
Other versions
FR2602145A1 (fr
Inventor
Gil Navon
Gianni Valensin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Original Assignee
Ramot at Tel Aviv University Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot at Tel Aviv University Ltd filed Critical Ramot at Tel Aviv University Ltd
Publication of FR2602145A1 publication Critical patent/FR2602145A1/fr
Application granted granted Critical
Publication of FR2602145B3 publication Critical patent/FR2602145B3/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR878710723A 1986-07-29 1987-07-29 Nouvel agent de contraste pour les images de rmn, particulierement utile aux applications medicales de la rmn Expired FR2602145B3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL79559A IL79559A0 (en) 1986-07-29 1986-07-29 Contrast agents for nmr medical imaging

Publications (2)

Publication Number Publication Date
FR2602145A1 FR2602145A1 (fr) 1988-02-05
FR2602145B3 true FR2602145B3 (fr) 1989-06-16

Family

ID=11056980

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878710723A Expired FR2602145B3 (fr) 1986-07-29 1987-07-29 Nouvel agent de contraste pour les images de rmn, particulierement utile aux applications medicales de la rmn

Country Status (4)

Country Link
DE (1) DE3724985A1 (fr)
FR (1) FR2602145B3 (fr)
GB (1) GB2193095A (fr)
IL (1) IL79559A0 (fr)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813144D0 (en) * 1988-06-03 1988-07-06 Nycomed As Compositions
US5705187A (en) 1989-12-22 1998-01-06 Imarx Pharmaceutical Corp. Compositions of lipids and stabilizing materials
US5305757A (en) 1989-12-22 1994-04-26 Unger Evan C Gas filled liposomes and their use as ultrasonic contrast agents
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5773024A (en) 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5656211A (en) 1989-12-22 1997-08-12 Imarx Pharmaceutical Corp. Apparatus and method for making gas-filled vesicles of optimal size
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5733572A (en) 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5334381A (en) * 1989-12-22 1994-08-02 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5230882A (en) * 1989-12-22 1993-07-27 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US6001335A (en) 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US20020150539A1 (en) 1989-12-22 2002-10-17 Unger Evan C. Ultrasound imaging and treatment
US5149319A (en) * 1990-09-11 1992-09-22 Unger Evan C Methods for providing localized therapeutic heat to biological tissues and fluids
US5123414A (en) * 1989-12-22 1992-06-23 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
US5352435A (en) * 1989-12-22 1994-10-04 Unger Evan C Ionophore containing liposomes for ultrasound imaging
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5088499A (en) * 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5469854A (en) 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
US5874062A (en) 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
US5385719A (en) * 1991-09-24 1995-01-31 Unger; Evan C. Copolymers and their use as contrast agents in magnetic resonance imaging and in other applications
EP1104678A2 (fr) 1992-05-04 2001-06-06 UNGER, Evan C Méthode de potention hypothermique de tissue
US7083572B2 (en) 1993-11-30 2006-08-01 Bristol-Myers Squibb Medical Imaging, Inc. Therapeutic delivery systems
US5736121A (en) 1994-05-23 1998-04-07 Imarx Pharmaceutical Corp. Stabilized homogenous suspensions as computed tomography contrast agents
US6743779B1 (en) 1994-11-29 2004-06-01 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
DE19500665A1 (de) * 1995-01-12 1996-07-18 Axel Prof Dr Haase Verfahren zur ortsauflösenden Abbildung eines Bereiches eines biologischen Objektes mit Hilfe elektromagnetischer Strahlen unter Applikation von Kontrastmittel
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
US6033645A (en) 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
ATE345682T1 (de) 1996-05-01 2006-12-15 Imarx Pharmaceutical Corp In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
US6143276A (en) 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US7452551B1 (en) 2000-10-30 2008-11-18 Imarx Therapeutics, Inc. Targeted compositions for diagnostic and therapeutic use
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US6123923A (en) 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
JP2000086538A (ja) * 1998-09-17 2000-03-28 Toshihiro Akaike Ｍｒｉ用造影剤
IL151128A0 (en) 2000-02-08 2003-04-10 Rice University Optically-active nanoparticles for use in therapeutic and diagnostic methods
DK1377320T3 (da) 2001-04-04 2009-02-09 Nordic Vaccine Technology As Polynukleotidbindingskomplekser omfattende steroler og saponiner
CA2650691C (fr) 2006-04-28 2015-10-06 Children's Hospital Medical Center Proprietes fusiogenes de la saposine c, et proteines et peptides connexes d'application aux systemes d'administration de medicaments transmembranaires
EP2741784B1 (fr) 2011-03-02 2017-05-17 Board Of Regents, The University Of Texas System Therapies de tusc2
CN110464709A (zh) 2012-08-10 2019-11-19 德克萨斯州大学系统董事会 用于治疗中风的神经保护性脂质体组合物和方法
WO2015117626A1 (fr) * 2014-02-07 2015-08-13 Rijksuniversiteit Groningen Oligo- et polyaminotétrazoles et leur utilisation dans des agents de contraste irm
EP3389650B1 (fr) 2015-12-18 2022-01-12 The Board of Regents of The University of Texas System Thérapeutiques pour la prise en charge du travail prématuré
KR102661905B1 (ko) 2016-10-12 2024-04-29 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 Tusc2 면역요법을 위한 방법 및 조성물
US10682411B2 (en) 2018-03-23 2020-06-16 Bexion Pharmaceuticals Inc. Saposin C pharmaceutical compositions and methods of treating cancer
KR20230005244A (ko) 2020-04-20 2023-01-09 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 생물학적 활성 건조 분말 조성물 및 이의 제조 및 사용 방법
US20230302154A1 (en) 2020-08-19 2023-09-28 The Board Of Regents Of The University Of Texas System Nanodrugs for targeted drug delivery and use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728575A (en) * 1984-04-27 1988-03-01 Vestar, Inc. Contrast agents for NMR imaging

Also Published As

Publication number Publication date
FR2602145A1 (fr) 1988-02-05
GB8717854D0 (en) 1987-09-03
DE3724985A1 (de) 1988-02-11
GB2193095A (en) 1988-02-03
IL79559A0 (en) 1986-10-31

Similar Documents

Publication Publication Date Title
FR2602145B3 (fr) Nouvel agent de contraste pour les images de rmn, particulierement utile aux applications medicales de la rmn
IT8223705A0 (it) Procedimento per la preparazione di composti cianoeterociclici.
DE68924762D1 (de) Stativ für eine Röntgenröhre.
DE3672816D1 (de) Kontrastmittel fuer nmr-abbildung.
DE69017370D1 (de) Röntgenuntersuchungsapparat.
DE59009531D1 (de) Röntgenröhre.
DK576486A (da) Kontrastmidler til nmr-afbildning
IT1243924B (it) Procedimento per la preparazione di dieteri
IT8919179A0 (it) Procedimento per la preparazione di composti basici di alluminio.
DE69010033D1 (de) Röntgenuntersuchungsapparat.
DE58905402D1 (de) Röntgenstrahler.
IT8622347A0 (it) Procedimento per la preparazione di polieteri alogenati.
MX163934B (es) Procedimiento para preparar haluros de 1-metil-3,5,7-triaza-1-azoniatriciclodecano
IT9067657A0 (it) Procedimento per la preparazione di alfa-alchil-lattoni.
IT9047829A0 (it) Metodo per la preparazione di eteri sostituiti.
ES530145A0 (es) Procedimiento de preparacion de compuestos bromados.
DE3750579D1 (de) Nmr-bildformungsverfahren.
FR2604235B1 (fr) Garniture d'etancheite pour piston hydraulique.
IT8421695A0 (it) Procedimento per la preparazione di 3, 11-dimetil-2-nonacosanone.
IT1231506B (it) Procedimento per la purificazione di polieteri polioli.
ES512194A0 (es) "procedimiento de preparar compuestos piridotienopiridacinicos".
IT8919209A0 (it) Procedimento per la preparazione di alfa bromoalcilfluoruri.
IT9022507A0 (it) Procedimento per la preparazione di n-(26ammino63,5-dibromo-benzil)-trans-4-amminocicloesanolo3.
IT8720078A0 (it) Procedimento per la preparazione di (+)-13-norfaranale.
ES511884A0 (es) "procedimiento de preparar compuestos beta-lactamicos".

Legal Events

Date Code Title Description
ST Notification of lapse